Product image of Maxidex (Dexamethasone) supplied by GNH India

Maxidex

Active Ingredient:
Dexamethasone
Origin:
EU

Maxidex (Dexamethasone)

Dexamethasone, the active ingredient in Maxidex, is a corticosteroid presented as a 0.1% w/v ophthalmic solution for ocular (topical) use. It treats postoperative ocular inflammation, uveitis, allergic conjunctivitis and other anterior segment inflammatory conditions in patients who require anti‑inflammatory therapy.

GNH India supplies Maxidex as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory‑approved batches to meet global demand. Our distribution network ensures reliable delivery across Europe, Asia, Africa and the Americas.

Manufacturer / TM Owner

Novartis Ireland Limited

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Maxidex (dexamethasone ophthalmic solution) is used to manage inflammatory conditions of the anterior eye segment.

  • Postoperative ocular inflammation: reduces swelling, pain and redness after eye surgery.
  • Uveitis: suppresses intra‑ocular inflammation to preserve visual acuity.
  • Allergic conjunctivitis: alleviates itching, redness and swelling caused by allergens.
  • Anterior segment inflammation: controls inflammatory response in the cornea and iris.

How It Works

  • Dexamethasone binds to intracellular glucocorticoid receptors, forming a complex that translocates to the nucleus and modulates gene transcription. This action down‑regulates pro‑inflammatory cytokines, chemokines and enzymes such as phospholipase A2, leading to decreased prostaglandin and leukotriene synthesis, reduced vascular permeability and inhibition of immune‑cell migration, thereby providing potent anti‑inflammatory effects in ocular tissues.

Side Effects

Topical ocular dexamethasone may cause a range of local and systemic adverse reactions.

Common Side Effects

  • Burning or stinging sensation upon instillation.
  • Temporary blurred vision.
  • Mild increase in intra‑ocular pressure.
  • Conjunctival hyperemia.

Serious or Rare Side Effects

  • Secondary ocular infection (bacterial, fungal or viral).
  • Significant elevation of intra‑ocular pressure leading to glaucoma.
  • Delayed corneal wound healing or ulceration.
  • Cataract formation with prolonged use.

Precautions & Warnings

When prescribing Maxidex, clinicians should observe several safety considerations.

  • Monitor intra‑ocular pressure: schedule regular eye‑pressure assessments during therapy.
  • Avoid use in active ocular infection: corticosteroid action may exacerbate bacterial, viral or fungal infections.
  • Do not wear contact lenses: lenses can trap the solution and reduce drug efficacy.
  • Review systemic steroid use: concurrent systemic corticosteroids increase risk of systemic side effects.
  • Store at room temperature: keep in the original container, protect from light and moisture.

Avoid Interactions

Maxidex can interact with other ophthalmic or systemic agents, influencing efficacy or safety.

Major Interactions (Avoid)

  • Other topical ocular corticosteroids: additive risk of intra‑ocular pressure rise and cataract.
  • Systemic immunosuppressants (e.g., cyclosporine): may enhance immunosuppression and infection risk.

Moderate Interactions (Monitor Closely)

  • Non‑steroidal anti‑inflammatory eye drops: possible reduction in anti‑inflammatory effect.
  • Beta‑blocker eye drops: may affect intra‑ocular pressure control.
  • Systemic CYP3A4 inducers (e.g., rifampin): may lower dexamethasone concentrations.

Frequently Asked Questions

Maxidex is indicated for the treatment of postoperative ocular inflammation, uveitis, allergic conjunctivitis and other anterior segment inflammatory conditions. It helps reduce swelling, pain, redness and itching in the eye, supporting recovery after surgery or managing immune‑mediated eye disorders.

Dexamethasone binds to glucocorticoid receptors inside ocular cells, altering gene expression. This suppresses the production of inflammatory cytokines, prostaglandins and leukotrienes, decreases vascular permeability, and limits immune‑cell infiltration, resulting in potent anti‑inflammatory activity within the eye.

The specific dosing regimen for Maxidex is determined by the prescribing ophthalmologist based on the severity of the condition, patient age and response to therapy. Typical regimens involve one or more drops applied to the affected eye(s) at intervals advised by the clinician.

Safety data for dexamethasone ophthalmic solution in pregnancy and lactation are limited, and the product is classified as pregnancy category unknown. Clinicians should weigh potential benefits against risks and consider alternative therapies when treating pregnant or nursing patients.

To request Maxidex, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Maxidex (0.1% dexamethasone) offers a high‑potency corticosteroid in a low‑volume ophthalmic solution, providing rapid anti‑inflammatory effects. Compared with lower‑potency agents such as prednisolone acetate 1%, dexamethasone may achieve similar control with fewer drops, but it also carries a higher risk of intra‑ocular pressure elevation, requiring careful monitoring.

Store Maxidex at room temperature, preferably below 25 °C, in the original container. Protect the bottle from direct sunlight, moisture and extreme temperature fluctuations. Keep the solution tightly sealed when not in use and discard any product that appears discolored or contaminated.

Wash hands thoroughly, tilt the head back and gently pull down the lower eyelid to create a pocket. Instill the prescribed number of drops without touching the tip of the bottle to the eye or surrounding tissues. Close the eye gently for a few seconds and avoid blinking excessively to allow absorption.

Serious risks include a significant rise in intra‑ocular pressure that can lead to glaucoma, secondary ocular infections (bacterial, fungal or viral), delayed corneal wound healing or ulceration, and cataract formation with prolonged use. Patients should be monitored regularly for these complications.

Maxidex is contraindicated in patients with known hypersensitivity to dexamethasone or any component of the formulation, and it should be avoided in eyes with active viral, fungal or bacterial infections unless directed by a specialist. Caution is also advised for individuals with uncontrolled glaucoma or severe cataract.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Dexamethasone

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT